Answers are grounded in this paper and cite their sources.
Systematic review demonstrates increased cardiovascular and renal risks in kidney transplant recipients with metabolic syndrome, suggesting need for improved management.
KTRs with MS are at significantly increased risk of adverse cardiovascular and renal outcomes. Further large-scale prospective cohort studies using standardized definitions are needed to strengthen causal inference and guide clinical management in this population.
No takes yet. Share an insight, caveat, or question.
Lim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: